Education
About Us
Working with TipRanks
Follow Us
JD Health International, Inc. (HK:6618)
:6618
6618 Stock Chart & Stats
HK$60.30
HK$0.45(1.61%)
At close: 4:00 PM EST
HK$60.30
HK$0.45(1.61%)
Day’s Range― - ―
52-Week RangeHK$27.15 - HK$71.70
Previous CloseN/A
Volume5.25M
Average Volume (3M)7.60M
Market Cap
HK$166.16B
Enterprise ValueHK$114.33B
Total Cash (Recent Filing)HK$47.00B
Total Debt (Recent Filing)HK$636.29M
Price to Earnings (P/E)30.1
Beta1.46
Next Earnings
Aug 13, 2026EPS Estimate
1.31Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.06
Shares Outstanding3,210,775,100
10 Day Avg. Volume6,883,323
30 Day Avg. Volume7,596,953
Financial Highlights & Ratios
PEG Ratio1.20
Price to Book (P/B)2.62
Price to Sales (P/S)2.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
HK$75.80Price Target Upside25.71% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering10
EPS Forecast (FY)1.85
Revenue Forecast (FY)HK$87.28B
Bulls Say, Bears Say
Bulls Say
Very Strong Balance Sheet And Low LeverageExtremely low leverage and a growing equity base provide durable financial flexibility to fund R&D, pharmacy rollout and AI investments without forcing dilutive equity or heavy debt. This conservatism reduces bankruptcy risk and supports multi-year strategic optionality amid industry competition.
Sustained Revenue Growth With Margin ExpansionDouble-digit revenue growth coupled with expanding gross margins indicates the business is achieving operational leverage and improving unit economics. Over 2–6 months this supports durable earnings improvement, giving management room to reinvest in growth while protecting profitability.
Strong Operating Cash Generation And Large Engaged User BaseHealthy operating cash flow funds ongoing investment without reliance on external financing, while a large, growing user base and high AI engagement create durable monetization optionality across services, insurance and on-demand retail as commercialization pathways mature.
Bears Say
Free-cash-flow Volatility And Recent Swing To Zero FCFA sharp swing in free cash flow to zero signals that investments or working-capital shifts materially alter cash conversion. Over the medium term this raises funding and capital-allocation risk: planned expansion or margin targets may require higher cash conversion to be sustainably financed.
High Revenue Concentration In Direct-sales ChannelWith ~83% of revenue from direct sales the company is exposed to supplier, category and channel-specific shocks. Limited diversification magnifies competitive or regulatory risks in core categories and could force margin-reducing tactics to defend market share over the next several quarters.
AI Monetization Remains Uncertain Despite High EngagementHigh engagement metrics do not guarantee revenue; converting AI and doctor-facing products into repeatable enterprise or consumer revenue will require sustained R&D, sales and integration effort. If monetization lags, expected margin and service-revenue upside may underdeliver.
JD Health International, Inc. News
6618 FAQ
What was JD Health International, Inc.’s price range in the past 12 months?
JD Health International, Inc. lowest stock price was HK$27.15 and its highest was HK$71.70 in the past 12 months.
What is JD Health International, Inc.’s market cap?
JD Health International, Inc.’s market cap is HK$166.16B.
When is JD Health International, Inc.’s upcoming earnings report date?
JD Health International, Inc.’s upcoming earnings report date is Aug 13, 2026 which is in 148 days.
How were JD Health International, Inc.’s earnings last quarter?
JD Health International, Inc. released its earnings results on Mar 05, 2026. The company reported HK$1.064 earnings per share for the quarter, beating the consensus estimate of HK$0.74 by HK$0.324.
Is JD Health International, Inc. overvalued?
According to Wall Street analysts JD Health International, Inc.’s price is currently Undervalued.
Does JD Health International, Inc. pay dividends?
JD Health International, Inc. does not currently pay dividends.
What is JD Health International, Inc.’s EPS estimate?
JD Health International, Inc.’s EPS estimate is 1.31.
How many shares outstanding does JD Health International, Inc. have?
JD Health International, Inc. has 3,210,775,100 shares outstanding.
What happened to JD Health International, Inc.’s price movement after its last earnings report?
JD Health International, Inc. reported an EPS of HK$1.064 in its last earnings report, beating expectations of HK$0.74. Following the earnings report the stock price went down -6.219%.
Which hedge fund is a major shareholder of JD Health International, Inc.?
Currently, no hedge funds are holding shares in HK:6618
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
JD Health International, Inc. Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
HK$75.80 (25.71% Upside)
HK$75.80 (25.71% Upside)
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
130.47%
12-Months-Change
Fundamentals
Return on Equity
9.03%
Trailing 12-Months
Asset Growth
19.80%
Trailing 12-Months
Company Description
JD Health International, Inc.
JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health supplements and tonics through direct selling and an online retail pharmacy network. The company also provides online healthcare services, online consultation, hospital or doctor referral, health check-ups, genetic testing, and beauty care services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, it offers access to medical checkups, medical aesthetics, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
6618 Stock 12 Month Forecast
Average Price Target
HK$75.80
▲(25.71% Upside)
Technical Analysis
Rici Healthcare Holdings Ltd.
―
Jinxin Fertility Group Ltd.
―
Gushengtang Holdings Limited
―
Guangdong Kanghua Healthcare Co., Ltd. Class H
―
Hygeia Healthcare Holdings Co., Ltd.
―
Options Prices
Currently, No data available
---